This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Dec;27(12):1737-9.

doi: 10.1007/s002590000322.

Positron emission tomography: imaging tumor response

J F Eary, K A Krohn

PMID: 11189933
DOI: 10.1007/s002590000322

Editorial

Positron emission tomography: imaging tumor response

J F Eary et al. Eur J Nucl Med. 2000 Dec.

. 2000 Dec;27(12):1737-9.

doi: 10.1007/s002590000322.

Authors

J F Eary, K A Krohn

PMID: 11189933
DOI: 10.1007/s002590000322

No abstract available

PubMed Disclaimer

Comment on

Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-D-glucose and positron emission tomography: an overview of different analytical methods.
Hoekstra CJ, Paglianiti I, Hoekstra OS, Smit EF, Postmus PE, Teule GJ, Lammertsma AA. Hoekstra CJ, et al. Eur J Nucl Med. 2000 Jun;27(6):731-43. doi: 10.1007/s002590050570. Eur J Nucl Med. 2000. PMID: 10901462 Review.

Similar articles

Measurement of tumor response using [18F]-2-fluoro-2-deoxy-D-glucose and positron-emission tomography.
Lammertsma AA. Lammertsma AA. J Clin Pharmacol. 2001 Jul;41(S7):104S-106S. J Clin Pharmacol. 2001. PMID: 11452713 No abstract available.
[Positron-emission tomography in oncology].
Carreras Delgado JL. Carreras Delgado JL. An R Acad Nac Med (Madr). 1997;114(2):445-70; discussion 470-8. An R Acad Nac Med (Madr). 1997. PMID: 9412252 Spanish. No abstract available.
Positron emission tomography (PET) in diagnostic oncology: is it a necessary tool today?
Price P. Price P. Eur J Cancer. 2000 Apr;36(6):691-3. doi: 10.1016/s0959-8049(00)00031-9. Eur J Cancer. 2000. PMID: 10762740 Review. No abstract available.
[Added value of positron emission tomography with fluoro-18-deoxyglucose as the tracer (FDG-PET) in clinical problem cases in oncology].
Soepenberg O. Soepenberg O. Ned Tijdschr Geneeskd. 2000 Oct 7;144(41):1979-80. Ned Tijdschr Geneeskd. 2000. PMID: 11048563 Dutch. No abstract available.
[Technique and indications in pediatric oncology. Positron emission tomography with 18F-fluorodeoxyglucose].
Foehrenbach H, Edeline V, Bonardel G, Neuenschwander S. Foehrenbach H, et al. Arch Pediatr. 2004 Apr;11(4):378-82. doi: 10.1016/j.arcped.2003.12.022. Arch Pediatr. 2004. PMID: 15051101 Review. French.

See all similar articles

Cited by

Statistical assessment of treatment response in a cancer patient based on pre-therapy and post-therapy FDG-PET scans.
Wolsztynski E, O'Sullivan F, O'Sullivan J, Eary JF. Wolsztynski E, et al. Stat Med. 2017 Mar 30;36(7):1172-1200. doi: 10.1002/sim.7198. Epub 2016 Dec 18. Stat Med. 2017. PMID: 27990685 Free PMC article.
Methodology for quantitative rapid multi-tracer PET tumor characterizations.
Kadrmas DJ, Hoffman JM. Kadrmas DJ, et al. Theranostics. 2013 Oct 4;3(10):757-73. doi: 10.7150/thno.5201. Theranostics. 2013. PMID: 24312149 Free PMC article. Review.
Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography.
Alazraki N. Alazraki N. J Gastrointest Surg. 2002 Mar-Apr;6(2):136-8. doi: 10.1016/s1091-255x(01)00058-0. J Gastrointest Surg. 2002. PMID: 11992797 Review. No abstract available.

References

1. Eur J Cancer. 1999 Dec;35(13):1773-82 - PubMed
1. J Clin Oncol. 2000 Mar;18(6):1351-9 - PubMed
1. J Clin Oncol. 2000 Apr;18(8):1676-88 - PubMed
1. J Clin Oncol. 2000 Apr;18(8):1689-95 - PubMed
1. Eur J Nucl Med. 2000 Jun;27(6):731-43 - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

P01 CA042045/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Springer